title: [New drug in atrial fibrillation--how does it function in regular health care?].
authors.forename: Margareta
authors.initials: M
authors.lastname: Holmström
authors.forename: Hans
authors.initials: H
authors.lastname: Johnsson
authors.forename: Gerd
authors.initials: G
authors.lastname: Lärfars
authors.forename: Rickard
authors.initials: R
authors.lastname: Malmström
authors.forename: Paul
authors.initials: P
authors.lastname: Hjemdahl
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D000069604:Dabigatran; D004059:Diffusion of Innovation; D019317:Evidence-Based Medicine; D006801:Humans; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D011725:Pyridines; D014859:Warfarin; D000069604:Dabigatran